Please login to the form below

Not currently logged in
Email:
Password:

Article 50

This page shows the latest Article 50 news and features for those working in and with pharma, biotech and healthcare.

UK businesses leaning towards second Brexit vote

UK businesses leaning towards second Brexit vote

May is resisting any moves to extend the Article 50 process under which the UK is due to leave the EU, and the Confederation of British Industry (CBI) has indicated that ... CBI director general Josh Hardie said: “If there were to be an extension [of

Latest news

More from news
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Leave or remain? Winning the employee referendum Leave or remain? Winning the employee referendum

    killer question: ‘Should I stay or should I go?’ Our decision to trigger the employee equivalent of Article 50 will normally be influenced by our experiences with our current employer. ... We all know you. can’t run a business on 50% turnover, but

  • The Patient Safety Challenge The Patient Safety Challenge

    The goal that the WHO’s document set is to ‘gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years’. ... International research collaboration. In this article, we describe a programme

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    50 negotiations, which could result in a new Government with a different set of policy priorities and an alternative approach to Brexit. ... However, the Chancellor, Philip Hammond, welcomed the CBI’s call for an ‘indefinite’ transition period

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    How Brexit affects pharma. The British Government submitted Article 50 in March 2017, formerly giving giving notice its intent to leave the EU.

  • Brexit: Implications for the pharma industry Brexit: Implications for the pharma industry

    Notice under Article 50 was given at the end of March 2017, triggering the start of the two-year period during which the UK’s withdrawal from the EU will be

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics